Results 11 to 20 of about 14,197,112 (305)

Early and Late Arrhythmogenic Effects of Doxorubicin

Southern Medical Journal, 2006
18587 Background: To determine the early and late arrhythmogenic effects of doxorubicin-containing chemotherapy regimens, and to identify associated risk. Methods: A prospective study including 29 patients who were treated with doxorubicin-containing regimens between September 2002 and September 2003.
Aksoy, Sercan, Barista, Ibrahim, Aytemir, Kudret, Kilickap, Saadettin, Tekuzman, Gulten, Akgul, Ebru   +5 more
openaire   +4 more sources

Late effects after thymectomy. [PDF]

Blood Adv
Parekh C.
europepmc   +3 more sources

Late Effects in Childhood Cancer Survivors: Early Studies, Survivor Cohorts, and Significant Contributions to the Field of Late Effects. [PDF]

, 2020
With improvement in cure of childhood cancer came the responsibility to investigate the long-term morbidity and mortality associated with the treatments accountable for this increase in survival.
de Vathaire, Florent, Haupt, Riccardo, Hawkins, Michael, Norsker, Filippa Nyboe, McBride, Mary L, Berbis, Julie, Kremer, Leontien C, Kuehni, Claudia E, Kenborg, Line, Pedersen, Camilla, Robison, Leslie L, Winther, Jeanette Falck, Armstrong, Gregory T, McBride ML, Winther JF, Kremer LC, Kuehni, Claudia, E, Kuehni CE, Haupt R, Hawkins M, Berbis J, Pedersen C, Norsker FN, Robison LL, Armstrong GT, Kremer, Leontien, C, Mcbride, Mary, L, de Vathaire F, Robison, Leslie, L, Armstrong, Gregory, T, Kenborg L, Gregory T. Armstrong, Filippa Nyboe Norsker, Leslie L. Robison, Camilla Pedersen, Riccardo Haupt, Line Kenborg, Julie Berbis, Michael Hawkins, Claudia E. Kuehni, Jeanette Falck Winther, Florent de Vathaire, Mary L. McBride, Leontien C. Kremer   +43 more
core   +3 more sources

Late effects of breast radiotherapy [PDF]

The Lancet, 2014
1 Haviland J S, Owen J R, Dewar J A, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 2013; 14: 1086–94. 2 Hopwood P, Haviland J S, Sumo G,et al.
Haviland, J.S., Bliss, J.M., Sydenham, M., Yarnold, J.R.   +3 more
openaire   +6 more sources

Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer

BMC Research Notes, 2017
Background Given the risk of developing acute and long-term adverse effects in patients receiving cisplatin-based chemotherapy for testicular cancer (TC), risk-reducing interventions, such as physical activity (PA), may be relevant.
Lene Thorsen, Camilla Kirkegaard, Jon Håvard Loge, Cecilie E. Kiserud, Merethe Lia Johansen, Gunhild M. Gjerset, Elisabeth Edvardsen, Hanne Hamre, Tone Ikdahl, Sophie D. Fosså   +9 more
doaj   +1 more source

Dedicated to eternity? The reuse of statue bases in late antique Italy [PDF]

, 2018
This chapter analyses the evidence for the reuse of inscribed statue bases from late antique Italy, arguing that rather than an occasional behaviour, this was an officially accepted practice.
Ribeiro Machado, Carlos Augusto
core   +2 more sources

Gender differences in self-reported late effects, quality of life and satisfaction with clinic in survivors of lymphoma [PDF]

, 2010
Objectives: gender differences in perceived vulnerability to late effects and views about follow-up among cancer survivors have received little attention.
B. W. Hancock, C. Eiser, Greenfield, D.M., R. E. Coleman, Hancock, B.W., Coleman, R.E., E. Arden-Close, Absolom, K., Arden-Close, Emily, null null, Eiser, C., D. M. Greenfield, Late Effects Group Sheffield, K. Absolom   +13 more
core   +1 more source

Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life

Haematologica, 2022
Lymphoma survivors after high-dose therapy with autologous stem-cell transplant (HDT-ASCT) are at risk of several late effects, which might impair their health-related quality of life (HRQoL). We assessed the total late effect burden in this population,
Knut Smeland, Harald Holte, Unn-Merete Fagerli, Hanne Bersvendsen, Marianne J. Hjermstad, Jon H. Loge, Klaus Murbrach, Marianne D. Linnsund, Oystein Fluge, Jo S. Stenehjem, May B. Lund, Stein Kvaloy, Cecilie E. Kiserud   +12 more
doaj   +1 more source

Norwegian reference data on the Fatigue Questionnaire and the Patient Health Questionnaire-9 and their interrelationship

Annals of General Psychiatry, 2020
Background Population-based reference data on frequently used questionnaires are important for comparative purposes. Due to changes in health and lifestyles, such data should be updated every other decade.
Alv A. Dahl, Kjersti Støen Grotmol, Marianne Jensen Hjermstad, Cecilie Essholt Kiserud, Jon Håvard Loge   +4 more
doaj   +1 more source

External beam radiotherapy of prostate cancer with or without high dose-rate brachytherapy: the Norwegian experience with long-term urinary and bowel adverse effects

Scandinavian Journal of Urology, 2023
Background: There are few studies utilizing the Expanded Prostate Index Composite questionnaire-26 (EPIC-26) questionnaire to examine the long-term association between Domain Summary Scores (DSSs) and Quality of Life (QoL) after External Beam Radiation ...
Trude B. Wedde, Milada C. Smaastuen, Kari Vatne, Melanie Birthe Schulz-Jaavall, Sophie D. Fosså, Wolfgang LH. Lilleby   +5 more
doaj   +1 more source